BIOSENSORS INTERNATIONAL ANNOUNCES ENROLLMENT OF FIRST PATIENT IN PIVOTAL TRIAL OF NEW CORONARY MICROCATHETER - "BIOMICS".
The BIOMICS study is a prospective, multi-center evaluation of the safety and effectiveness of the Biosensors Microcatheter in patients undergoing Percutaneous Coronary Intervention (PCI) for the treatment of chronic total occlusions (CTO).
Temporary pacemakers
Permanent pacemakers
Temporary pacemaker leads
Home Monitoring 
Instruments